A detailed history of Clarius Group, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 1,823 shares of ELV stock, worth $731,916. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,823
Previous 1,879 2.98%
Holding current value
$731,916
Previous $1.02 Million 6.97%
% of portfolio
0.07%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$500.12 - $562.29 $28,006 - $31,488
-56 Reduced 2.98%
1,823 $947,000
Q2 2024

Jul 11, 2024

SELL
$497.49 - $547.8 $29,849 - $32,868
-60 Reduced 3.09%
1,879 $1.02 Million
Q1 2024

Apr 17, 2024

SELL
$464.61 - $519.96 $129,161 - $144,548
-278 Reduced 12.54%
1,939 $1.01 Million
Q4 2023

Jan 29, 2024

SELL
$433.51 - $488.06 $9,103 - $10,249
-21 Reduced 0.94%
2,217 $1.05 Million
Q3 2023

Oct 19, 2023

SELL
$414.13 - $475.93 $271,669 - $312,210
-656 Reduced 22.67%
2,238 $974,000
Q2 2023

Aug 09, 2023

BUY
$436.33 - $496.2 $27,052 - $30,764
62 Added 2.19%
2,894 $1.29 Million
Q1 2023

Apr 17, 2023

SELL
$446.3 - $502.2 $20,976 - $23,603
-47 Reduced 1.63%
2,832 $1.3 Million
Q4 2022

Jan 25, 2023

BUY
$465.23 - $546.77 $33,961 - $39,914
73 Added 2.6%
2,879 $1.48 Million
Q3 2022

Oct 24, 2022

BUY
$445.98 - $507.0 $26,758 - $30,420
60 Added 2.18%
2,806 $1.28 Million
Q2 2022

Aug 10, 2022

BUY
$444.32 - $529.84 $70,646 - $84,244
159 Added 6.15%
2,746 $1.33 Million
Q4 2021

Feb 02, 2022

BUY
$370.08 - $467.67 $5,551 - $7,015
15 Added 0.58%
2,587 $1.2 Million
Q3 2021

Oct 18, 2021

BUY
$357.51 - $398.13 $27,885 - $31,054
78 Added 3.13%
2,572 $959,000
Q2 2021

Aug 06, 2021

SELL
$352.19 - $401.9 $6,339 - $7,234
-18 Reduced 0.72%
2,494 $952,000
Q1 2021

Apr 27, 2021

BUY
$287.7 - $371.31 $117,669 - $151,865
409 Added 19.45%
2,512 $902,000
Q4 2020

Jan 15, 2021

BUY
$270.17 - $333.15 $19,992 - $24,653
74 Added 3.65%
2,103 $675,000
Q3 2020

Oct 09, 2020

SELL
$245.73 - $284.63 $67,330 - $77,988
-274 Reduced 11.9%
2,029 $545,000
Q2 2020

Jul 08, 2020

BUY
$203.3 - $300.59 $54,891 - $81,159
270 Added 13.28%
2,303 $606,000
Q1 2020

Apr 24, 2020

BUY
$174.68 - $307.74 $53,102 - $93,552
304 Added 17.58%
2,033 $462,000
Q4 2019

Jan 22, 2020

SELL
$234.82 - $306.42 $5,870 - $7,660
-25 Reduced 1.43%
1,729 $521,000
Q3 2019

Oct 23, 2019

BUY
$237.69 - $310.48 $144,040 - $188,150
606 Added 52.79%
1,754 $421,000
Q2 2019

Aug 02, 2019

SELL
$236.25 - $293.76 $9,450 - $11,750
-40 Reduced 3.37%
1,148 $324,000
Q1 2019

May 14, 2019

BUY
$248.42 - $317.42 $295,122 - $377,094
1,188 New
1,188 $341,000
Q3 2018

Nov 13, 2018

SELL
$238.27 - $274.12 $249,230 - $286,729
-1,046 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$220.13 - $245.16 $230,255 - $256,437
1,046 New
1,046 $249,000

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.4B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.